[ad_1]
Kuala Lumpur, Malaysia July 5, 2018 / PRNewswire / – The CCM Duopharma Biotech Berhad (CCM Duopharma) received two awards at the annual Frost & Sullivan Awards of Excellence Banquet in Malaysia , held at Hilton Kuala Lumpur. The two awards received by CCM Duopharma include the pharmaceutical company 's (generic) year' s. 2018 year of Frost & Sullivan (Malaysia) and the halal pharmaceutical company of the year
. Rhenu Bhuller, Partner and Senior Vice President, Transformational Health, Asia-Pacific at Frost & Sullivan pointed out that CCM Duopharma focuses on best practices and a robust growth strategy, wins a strategic advantage in the region. "The ASEAN health care market should be worth $ 137 billion by 2025 with opportunities for generic and halal pharmaceuticals and biosimilars because of the need for affordable care that meets the market developments.With the profile of the disease in the region, areas such as oncology, cardiovascular disease and diabetes will continue to have high unmet needs, "she explained.
The company is also focused on differentiation
"With a vision to support health care needs not only today but for the future, CCM Duopharma is working to Ensuring that Malaysians and consumers ASEAN can access quality, affordable and user-friendly products The company is leading the way in the region through its product portfolio, research projects and development and partnership strategies, "said Rhenu Bhuller. (Generics) and Halal Pharmaceutical Company of the Year awarded by Frost & Sullivan, " Leonard Ariff Abdul Shatar General Manager of the CCM Duopharma Biotech Berhad.
Recipients of the annual Frost & Sullivan Malaysia Awards The awards for excellence were identified on the basis of extensive research conducted by Frost & Sullivan's analysts. The award categories offered each year are carefully reviewed and evaluated for reflect the current market landscape and include new emerging trends. market performance indicators that include revenue growth, market share and market share growth, leadership in product innovation, marketing strategy
About Frost & Sullivan
Frost & Sullivan, the growth limited partnership, works collaboratively with its clients to capitalize on visionary innovation that addresses global challenges and related growth opportunities. make or break market participants today.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging companies, the public sector and the investment community. Is your organization ready for the next wave of industry convergence, disruptive technologies, intensifying competition, mega trends, revolutionary best practices, changing dynamics? customer and emerging economies? www.frost.com
About CCM Duopharma Biotech Berhad ("CCM Duopharma")
Duopharma is engaged in the development, manufacture and commercialization of generic drugs and health products brand. It is the leading pharmaceutical manufacturer in Malaysia and a key regional player that offers a wide range of products in the form of tablets, capsules, syrup, oral antibiotics, creams, hemodialysis solution, solution Sterile irrigation, sterile injectable powder, small volume injectables, dental cartridges and eye drops preparations.
Its product portfolio promotes wellness at all stages of life, from prevention to treatment and healing. It produces more than 200 generic drugs, including award-winning drugs such as Omesec and Vascor while its Over-The-Counter brands such as Champs, Flavettes, Proviton and Uphamol are well recognized and accepted by consumers in Malaysia and regionally.
It is the first pharmaceutical company to receive Halal Pharmaceuticals certification based on the world's first Halal Pharmaceuticals standard: MS2424: 2012 "Halal Pharmaceuticals – General Guidelines" and also listed in the Malaysian Book of Records in 2013.
Media Contact
Melissa Tan
Corporate Communications – Asia-Pacific
P: +65 6890 0926
F: +65 6890 0999
E: Melissa .tan @ frost.com
Related links:
news POST
Buy this item for republication.
Source link
